Acquired <scp>TET</scp>2 mutation in one patient with familial platelet disorder with predisposition to <scp>AML</scp> led to the development of pre‐leukaemic clone resulting in T2‐<scp>ALL</scp> and <scp>AML</scp>‐M0
Journal of Cellular and Molecular Medicine